Patient profiling in HFrEF to tailor therapy - PACE-CME

Patient profiling in HFrEF to tailor therapy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Beneficial effects of MRAs in HF across the LVEF spectrum
Beneficial effects of MRAs in HF across the LVEF spectrum
ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
- Pardeep Jhund, MD, PhD
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
ESC Congress 2024
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
- Scott Solomon, MD
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
MinuteCE®
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
0.75 program credits
- Gianluigi Savarese, MD
0.75 program credits